Clinical Trials Logo
  1. Home
  2. Covid19
  3. NCT04945564
  4. Details
NCT04945564 Clinical Trial

Covid-19 Patients Management During Home Isolation

Covid19 Clinical Trial

Official title:
Covid-19 Patients Management During Home Isolation

Clinical Trial Details — Status: Active, not recruiting

Administrative data
NCT number NCT04945564
Other study ID # REC/036-2021
Secondary ID
Status Active, not recruiting
Phase N/A
First received
Last updated
Start date June 30, 2021
Est. completion date August 31, 2021

Study information
Verified date June 2021
Source Cairo University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The study will investigate management of Covid-19 patients in home isolation.

Description:

A clinical trial concerned with the treatment of home isolated COVID-19 patients

Recruitment information / eligibility
Status Active, not recruiting
Enrollment 60
Est. completion date August 31, 2021
Est. primary completion date August 30, 2021
Accepts healthy volunteers No
Gender All
Age group 20 Years to 42 Years
Eligibility Inclusion Criteria: - Covid-19 patients American Society of Anesthesiologists (ASA) class I >= 21 years old <= 40 years old Exclusion Criteria: - Not being consistent with home-isolation regimen

Study Design

Related Conditions & MeSH terms

Intervention

Procedure:
• Oxygen therapy and physical therapy
Patients receive oxygen therapy and physical therapy
Device:
• Oxygen therapy
Patients receive oxygen therapy

Locations
Country Name City State
Egypt A. Sedky Cairo

Sponsors (1)
Lead Sponsor Collaborator
Cairo University

Country where clinical trial is conducted

Egypt, 

Outcome
Type Measure Description Time frame Safety issue
Primary Time for recovery of pH Acidity Potential Hydrogen 24 hours
Primary Time for recovery of PaO2 Partial Pressure of Oxygen 24 hours
Primary Time for recovery of PaCO2 Partial Pressure of Carbon Dioxide 24 hours
Primary Chest CT scan Chest computed tomography scan Baseline
Primary Chest CT scan Chest computed tomography scan 1 day post-treatment
Secondary Time for recovery of Temperature vital sign 24 hours
Secondary Time for recovery of Respiratory Rate vital sign 24 hours
Secondary Time for recovery of Oxygen Saturation vital sign 24 hours
Secondary Time for recovery of Heart Rate vital sign 24 hours
Secondary Time for recovery of Blood Pressure vital sign 24 hours
See also
  Status Clinical Trial Phase
Completed NCT05047692 - Safety and Immunogenicity Study of AdCLD-CoV19-1: A COVID-19 Preventive Vaccine in Healthy Volunteers Phase 1
Recruiting NCT04395768 - International ALLIANCE Study of Therapies to Prevent Progression of COVID-19 Phase 2
Completed NCT04508777 - COVID SAFE: COVID-19 Screening Assessment for Exposure
Terminated NCT04555096 - A Trial of GC4419 in Patients With Critical Illness Due to COVID-19 Phase 2
Completed NCT04506268 - COVID-19 SAFE Enrollment N/A
Completed NCT04961541 - Evaluation of the Safety and Immunogenicity of Influenza and COVID-19 Combination Vaccine Phase 1/Phase 2
Active, not recruiting NCT04546737 - Study of Morphological, Spectral and Metabolic Manifestations of Neurological Complications in Covid-19 Patients N/A
Terminated NCT04581915 - PHRU CoV01 A Trial of Triazavirin (TZV) for the Treatment of Mild-moderate COVID-19 Phase 2/Phase 3
Completed NCT04494646 - BARCONA: A Study of Effects of Bardoxolone Methyl in Participants With SARS-Corona Virus-2 (COVID-19) Phase 2
Completed NCT04532294 - Safety, Tolerability, Pharmacokinetics, and Immunogenicity of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2/COVID-19) Neutralizing Antibody in Healthy Participants Phase 1
Not yet recruiting NCT04543006 - Persistence of Neutralizing Antibodies 6 and 12 Months After a Covid-19 N/A
Terminated NCT04542993 - Can SARS-CoV-2 Viral Load and COVID-19 Disease Severity be Reduced by Resveratrol-assisted Zinc Therapy Phase 2
Not yet recruiting NCT04527211 - Effectiveness and Safety of Ivermectin for the Prevention of Covid-19 Infection in Colombian Health Personnel Phase 3
Completed NCT04507867 - Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III N/A
Completed NCT04537663 - Prevention Of Respiratory Tract Infection And Covid-19 Through BCG Vaccination In Vulnerable Older Adults Phase 4
Completed NCT04387292 - Ocular Sequelae of Patients Hospitalized for Respiratory Failure During the COVID-19 Epidemic N/A
Completed NCT04979858 - Reducing Spread of COVID-19 in a University Community Setting: Role of a Low-Cost Reusable Form-Fitting Fabric Mask N/A
Not yet recruiting NCT05038449 - Study to Evaluate the Efficacy and Safety of Colchicine Tablets in Patients With COVID-19 N/A
Completed NCT04610502 - Efficacy and Safety of Two Hyperimmune Equine Anti Sars-CoV-2 Serum in COVID-19 Patients Phase 2
Active, not recruiting NCT06042855 - ACTIV-6: COVID-19 Study of Repurposed Medications - Arm G (Metformin) Phase 3